Pharma News

Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.

Sobi Acquires CTI BioPharma

Wednesday, May 10, 2023

Swedish Orphan Biovitrum AB publ Sobi announced that it has entered into an agreement and plan of merger with CTI BioPharma under which Sobi has agreed to acquire CTI a biopharmaceutical company focused on blood related cancers and rare diseases by m...

Astrazeneca Announces Approval of Ultomiris (ravulizumab) in the European Union (EU)

Wednesday, May 10, 2023

Astrazeneca announced the approval of Ultomiris ravulizumab in the European Union EU as the first and only longacting C complement inhibitor for the treatment of adult patients with antiaquaporin AQP antibodypositive Ab neuromyelitis optica spectrum...

Bayer and Bicycle Therapeutics Enter into Strategic Collaboration

Wednesday, May 10, 2023

Bayer and Bicycle Therapeutics announced that they have entered into a strategic collaboration agreement to discover develop manufacture and commercialise Bicycle radioconjugates for multiple agreed upon oncology targets

Mitsubishi Tanabe Pharma Announces Approval of RADICAVA® Oral Suspension in Switzerland

Wednesday, May 10, 2023

Mitsubishi Tanabe Pharma Corporation announced that its wholly owned subsidiary Mitsubishi Tanabe Pharma obtained the approval from Authority of Switzerland Swissmedic to RADICAVA Oral Suspension for the indication of amyotrophic lateral sclerosis RA...

Recursion Enters into Agreements to Acquire Cyclica and Valence

Tuesday, May 09, 2023

Recursion announced it has signed agreements to acquire Cyclica and Valence to bolster chemistry and generative AI capabilities

Eyenovia Announces FDA Approval of Mydcombi™

Tuesday, May 09, 2023

Eyenovia announced that the US Food and Drug Administration FDA has approved Mydcombi tropicamide and phenylephrine hydrochloride ophthalmic spray for inducing mydriasis for diagnostic procedures and in conditions where short term pupil dilation is...

CureVac Announces Dosing of First Participant Developed in Collaboration with GSK

Tuesday, May 09, 2023

CureVac announced that the first participant was dosed in the Phase part of a combined Phase study of multivalent modified mRNA seasonal flu vaccine candidates developed in collaboration with GSK The tested multivalent vaccine candidates address al...

ProMIS Neurosciences Announces FDA Clearance of Investigational New Drug (IND) Application for PMN310

Tuesday, May 09, 2023

ProMIS Neurosciences announced that it has received clearance from the US Food and Drug Administration FDA for its Investigational New Drug IND application for PMN for the treatment of AD

Trevena Announces Approval of OLINVYK in China

Tuesday, May 09, 2023

Trevena announced that its partner in China Jiangsu Nhwa received formal approval from the National Medical Products Administration for OLINVYK It has been approved for use in adults for the management of acute pain severe enough to require an intrav...

Gilead Sciences Acquires XinThera to Strengthen Early Pipeline in Oncology

Tuesday, May 09, 2023

Gilead Sciences announced the acquisition of all outstanding shares of XinThera The acquisition complements Gileads existing clinical development priorities by adding additional pipeline assets for wellvalidated targets in oncology and inflammation